On December 4, 2023, the 2023 annual meeting for the project entitled “Mechanism and Intervention Targets of Drug-induced Organ Development Programming and Disease Susceptibility”, which is a pivotal project under the national key research program entitled “Development Programming and Metabolic Regulation”, took place in Hefei. The event was sponsored by Wuhan University and organized by our university. Our Vice President, Mr. LYU Xiongwen, attended the occasion and eloquently delivered an oration.
The chief expert of the project, Professor Wang Hui of Wuhan University, presented an annual review of the project’s advancements. Concurrently, the directors and the key researchers of each sub-project meticulously reported the objectives and current performance, the progress and notable achievements, as well as the potential breakthroughs of their work. Following these presentations, the expert panel’s consensus was that the project has been advancing in a satisfactory manner, has achieved several outcomes of originality, and has nurtured a considerable number of excellent scholars. The panel recommended that the research team accelerate the clinical research and the transformation of medical findings to bolster the advancement of China’s scientific and technological innovation endeavors. Additionally, the experts offered strategic instructions on the integration of subprojects and the highlighting of key accomplishments.
It has been reported that Professor Xu Dexiang and Professor Wang Hua from School of Public Health at our university, with their research teams, participated in the project’s application and approval in 2020, which is an outstanding accomplishment for our university’s ongoing endeavors to build a prestigious university of medical studies.